Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Get Free Report) shares hit a new 52-week high on Wednesday . The stock traded as high as $30.71 and last traded at $30.5560, with a volume of 370087 shares trading hands. The stock had previously closed at $29.53.
Analysts Set New Price Targets
A number of research analysts have recently commented on ACHC shares. UBS Group increased their price objective on Acadia Healthcare from $27.00 to $31.00 and gave the company a “buy” rating in a report on Friday, April 17th. Weiss Ratings reiterated a “sell (d)” rating on shares of Acadia Healthcare in a report on Friday, June 12th. Guggenheim upped their price target on shares of Acadia Healthcare from $26.00 to $31.00 and gave the company a “buy” rating in a report on Monday, May 4th. Jefferies Financial Group upgraded Acadia Healthcare from a “hold” rating to a “buy” rating and lifted their price objective for the stock from $24.50 to $30.00 in a research note on Wednesday, June 3rd. Finally, TD Cowen increased their target price on Acadia Healthcare from $24.00 to $30.00 and gave the company a “buy” rating in a research note on Tuesday, April 28th. One investment analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, five have issued a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat, Acadia Healthcare presently has a consensus rating of “Hold” and an average target price of $26.85.
View Our Latest Stock Report on Acadia Healthcare
Acadia Healthcare Trading Up 2.9%
Acadia Healthcare (NASDAQ:ACHC – Get Free Report) last announced its quarterly earnings data on Wednesday, April 29th. The company reported $0.37 EPS for the quarter, topping analysts’ consensus estimates of $0.28 by $0.09. The company had revenue of $828.80 million during the quarter, compared to the consensus estimate of $823.51 million. Acadia Healthcare had a positive return on equity of 7.09% and a negative net margin of 32.84%.The company’s quarterly revenue was up 7.6% on a year-over-year basis. During the same quarter last year, the company earned $0.40 EPS. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS. Research analysts predict that Acadia Healthcare Company, Inc. will post 1.5 EPS for the current fiscal year.
Hedge Funds Weigh In On Acadia Healthcare
A number of hedge funds and other institutional investors have recently made changes to their positions in the business. EverSource Wealth Advisors LLC increased its stake in Acadia Healthcare by 54.8% in the second quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock valued at $32,000 after acquiring an additional 497 shares during the period. Federated Hermes Inc. lifted its stake in Acadia Healthcare by 1.5% during the fourth quarter. Federated Hermes Inc. now owns 43,913 shares of the company’s stock worth $623,000 after purchasing an additional 668 shares during the period. Price T Rowe Associates Inc. MD lifted its stake in Acadia Healthcare by 0.9% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 74,907 shares of the company’s stock worth $1,063,000 after purchasing an additional 696 shares during the period. Public Employees Retirement System of Ohio boosted its holdings in Acadia Healthcare by 2.8% during the third quarter. Public Employees Retirement System of Ohio now owns 31,335 shares of the company’s stock valued at $776,000 after purchasing an additional 867 shares in the last quarter. Finally, Treasurer of the State of North Carolina grew its stake in shares of Acadia Healthcare by 2.1% in the 2nd quarter. Treasurer of the State of North Carolina now owns 42,502 shares of the company’s stock valued at $964,000 after purchasing an additional 867 shares during the period.
Acadia Healthcare Company Profile
Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.
Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.
Further Reading
- Five stocks we like better than Acadia Healthcare
- Nike Q4 Beat Masks Core Weakness as Analysts Cut Price Targets
- Uber’s Waymo Detour Tests the Stock’s Robotaxi Bull Case
- Hershey Stock May Be Near a Sweet Spot as Cocoa Pressure Eases
- Comcast’s NBCUniversal Split Puts Broadband Back in Focus
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
